The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Dermatitis Herpetiformis (Advanced)

Cutaneous manifestation of celiac disease: pathogenesis, gluten-free diet, and dapsone therapy

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dermatoloji department. Book Appointment →

What is Dermatitis Herpetiformis (Advanced)?

DH affects 11.2 per 100,000 in Western populations, with strong association to celiac disease (>90% have gluten-sensitive enteropathy on biopsy, often subclinical). Genetic basis: HLA-DQ2 (>90%) or HLA-DQ8 association, similar to celiac disease. Onset typically in third-fourth decade, M:F ratio 1.5:1.

Pathogenesis: gluten ingestion triggers IgA antibody production against tissue transglutaminase (tTG/TG2) and epidermal transglutaminase (eTG3, TG3); IgA-eTG3 immune complexes deposit at dermoepidermal junction, particularly in dermal papillary tips, recruiting neutrophils that cause subepidermal blistering. Diagnostic gold standard: direct immunofluorescence of perilesional skin showing granular IgA in dermal papillae.

Diagnosis: clinical features + DIF (granular IgA deposits in papillary dermis - PATHOGNOMONIC) + serology (anti-tTG IgA, anti-DGP, anti-eTG3, EMA), small bowel biopsy (villous atrophy in 70-80%). Treatment: lifelong strict gluten-free diet (eliminates skin and bowel disease over months-years), dapsone for symptomatic relief (initial 50-100 mg/day, titrate to response). Sulfasalazine or sulfapyridine for dapsone-intolerant patients.

Symptoms

Intensely pruritic, burning, stinging vesicles and papules
Symmetric distribution on extensor surfaces: elbows (90%), knees, buttocks, scalp, shoulders
Grouped (herpetiform) vesicles - hence the name
Excoriations and crusts (vesicles often scratched away)
Post-inflammatory hyperpigmentation
Oral involvement uncommon (unlike pemphigus/EBA)
Gastrointestinal symptoms often subclinical (only 20% symptomatic)
Iron deficiency anemia, vitamin deficiencies (B12, folate, fat-soluble vitamins)

Risk Factors

HLA-DQ2 or HLA-DQ8 genotype (>95% positivity)
Family history of celiac disease or DH
Gluten consumption (wheat, barley, rye)
Northern European ancestry (highest prevalence)
Associated autoimmune diseases: thyroid disease (5-15%), type 1 diabetes (2-5%), pernicious anemia, vitiligo, alopecia areata
Increased risk of intestinal lymphoma (small bowel T-cell lymphoma) - reduced by GFD adherence

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Intensely itchy, symmetric blistering rash on elbows, knees, buttocks
  • Recurrent vesicles that heal with hyperpigmentation
  • Family history of celiac with skin symptoms
  • Worsening with bread/wheat consumption
  • Anemia, fatigue, GI symptoms with skin rash
  • Failed previous treatment for eczema/scabies
  • Skin symptoms recurring after dietary lapses

Treatment Methods

01
Strict lifelong gluten-free diet (cornerstone - addresses both skin and intestine)
02
Dapsone (50-100 mg/day initial, max 200 mg) - rapid symptomatic relief in 24-72 hours
03
G6PD screening before dapsone (hemolysis risk)
04
Sulfasalazine (1-1.5 g BID) or sulfapyridine - dapsone alternatives
05
Topical corticosteroids (high potency) for symptomatic relief
06
Antihistamines (limited efficacy for DH itch)
07
Iron, B12, folate, calcium supplementation
08
Dietitian consultation (gluten-free diet education)
09
Bone density assessment (osteoporosis screening)
10
Annual celiac disease serology, endoscopy if indicated
11
Lymphoma surveillance (long-standing untreated disease)
12
Medic-alert for dapsone (drug interactions)
13
Genetic counseling for affected families

Which Department to Visit?

You can visit our Dermatoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dermatoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Eczema (Atopic Dermatitis)

Dermatoloji

Atopic dermatitis is a chronic skin disease commonly seen especially in children, flaring with genetic predisposition and environmental triggers.

Psoriasis

Dermatoloji

Psoriasis is an autoimmune disease in which skin cells proliferate rapidly when the immune system mistakenly attacks the skin, leading to thick scaly lesions.

Acne

Dermatoloji

Acne is a skin disease resulting from clogging of hair follicles with oil and dead skin cells, commonly seen in adolescence but can occur at any age.

Rosacea

Dermatoloji

Rosacea is a chronic inflammatory facial skin disease characterized by recurrent flushing, persistent erythema, telangiectasia, and inflammatory papules and pustules. Phymatous change and ocular involvement may complicate advanced disease.

Urticaria (Hives)

Dermatoloji

Urticaria is a skin condition with sudden pink-red wheals and intense itching that may follow an acute or chronic course.

Skin Fungal Infections

Dermatoloji

Skin fungal infections are common, contagious skin diseases caused by dermatophytes and yeast fungi colonizing the upper layers of the skin.

Hair Loss (Alopecia)

Dermatoloji

Alopecia is a general term for hair loss that can be genetic, hormonal, autoimmune, or nutritional; early intervention can slow progression.

Vitiligo

Dermatoloji

Vitiligo is an acquired autoimmune disease in which CD8+ T cells destroy melanocytes, producing well-demarcated depigmented patches. Early, sustained treatment can induce repigmentation and prevent progression; psychosocial impact warrants holistic care.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.